Informazioni su Codexis, Inc. - Common Stock Panoramica della società da Wikipedia

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

History

Codexis is based in Redwood City, CA and was incorporated in 2002. It went public in April 2010 on NASDAQ, and in October, acquired Maxygen's MolecularBreeding technology portfolio.

Pharmaceutical

Codexis won the Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency (EPA) in 2006 for its work on a building block of Lipitor. It then won a second time in 2010 for its work with Merck & Co. on the active ingredient in Januvia.

Nutrition

In 2017, the company entered a partnership with Tate & Lyle to provide research and development for the production of new ingredients. That same year, Codexis announced a collaboration with Nestle to provide enzymes for metabolic disorders.

Biotherapeutics

In 2017, Codexis developed a recombinant phenylalanine ammonia-lyase (PAL) enzyme, to act as a substitute phenylalanine hydroxylase (PAH) enzyme for people who suffer from phenylketonuria. The enzyme was in-licensed by Nestle Health Sciences.

In 2020, Takeda Pharmaceutical announced a collaboration with Codexis to research and create gene therapies for rare diseases, including lysosomal storage disorders.

Life science

In June 2020, they announced a partnership with Molecular Assemblies to engineer enzymes for DNA synthesis.

Technology

Codexis uses directed evolution to develop its enzymes. Using this method, scientists genetically engineer genes, then screen the enzymes produced to see if it creates the properties needed for a specific reaction. Their protein engineering platform, called CodeEvolver, uses machine learning and high-throughput experimentation to learn protein sequence changes and their impacts on protein function.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

CDXS Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$1.56

Capitalizzazione di Mercato

$142M

P/E (TTM)

-3.1

EPS (TTM)

$-0.50

Ricavi (TTM)

$70M

Rendimento div.

—

ROE

-82.8%

D/E Debito/Patrimonio

0.8

Intervallo 52 sett.

$1 – $3

CDXS Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $70M

2016-12-31 → 2025-12-31

EPS $-0.50

2019-12-31 → 2025-12-31

Flusso di cassa libero $-24M

2016-12-31 → 2025-12-31

Margini -62.5%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

CDXS

Mediana dei peer

P/E (TTM)

-3.1

17.5

P/S (TTM)

2.0

3.3

P/B

2.8

2.1

EV / EBITDA

-2.8

—

Price / FCF (Prezzo / FCF)

-5.9

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

CDXS

Mediana dei peer

Operating Margin (Margine Operativo)

-59.3%

—

Net Profit Margin (Margine di Profitto Netto)

-62.5%

-56.5%

ROA

-29.6%

-17.2%

ROE

-82.8%

-41.3%

ROIC

-46.1%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

CDXS

Mediana dei peer

Debt / Equity (Debito / Patrimonio Netto)

0.8

369.6

Current Ratio (Rapporto corrente)

3.8

4.9

Quick Ratio

3.1

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

CDXS

Mediana dei peer

Revenue YoY (Ricavi YoY)

18.6%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

-20.2%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

0.38%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

CDXS

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$-0.50

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

CDXS

Mediana dei peer

CDXS Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 13 analisti

Acquisto forte 4 30,8%
Compra 6 46,2%
Mantieni 3 23,1%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

6 analisti · 2026-08-13

Mediana $7.00

← Sotto tutti i target $1.56

Basso $2.00

Alto $11.00

Target mediano $7.00 +347,3%

Target medio $6.58 +320,7%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

0.01%

Periodo	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	$-0.13	$-0.14	0.01%
31 Marzo 2026	$-0.10	$-0.14	0.04%
31 Dicembre 2025	$0.11	$-0.04	0.15%
30 Settembre 2025	$-0.22	$-0.15	-0.07%
30 Giugno 2025	$-0.16	$-0.19	0.03%
31 Marzo 2025	$-0.25	$-0.24	-0.01%
31 Dicembre 2024	$-0.13	$-0.04	-0.09%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
CDXS	$147M	-3.3	18.6%	-62.5%	-82.8%	—
DNA	$484M	-1.5	-25.1%	-183.8%	-55.8%	—
TKNO	$204M	-11.9	7.3%	-42.6%	-23.8%	33.2%
PACB	$565M	-1.0	3.9%	-341.5%	-1634.9%	28.6%
LAB	$495M	-6.4	-6.2%	-87.8%	-17.6%	49.9%
LFCR	$249M	-5.3	0.47%	-30.0%	-461.3%	31.3%
QSI	—	—	—	—	—	—
MXCT	$166M	-3.7	-14.5%	-135.1%	-24.6%	81.2%
QTRX	$297M	-2.5	1.1%	-77.1%	-36.4%	46.8%
SEER	—	-1.4	17.0%	—	—	—
NAUT	$247M	-4.1	—	—	-34.9%	—

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 16

Dati annuali Conto Economico per CDXS
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$70M	$59M	$70M	$139M	$105M	$69M	$68M	$61M	$50M	$49M	$42M	$35M
Cost of Revenue	$9M	$16M	$13M	$38M	$22M	$14M	$16M	$13M	$14M	$10M	$7M	$10M
R&D Expense	$52M	$46M	$59M	$80M	$56M	$44M	$34M	$30M	$30M	$22M	$21M	$23M
SG&A Expense	$47M	$55M	$53M	$52M	$49M	$35M	$32M	$29M	$29M	$25M	$22M	$22M
Operating Expenses	$112M	$118M	$138M	$173M	$127M	$93M	$81M	$72M	$73M	$57M	$50M	$54M
Operating Income	$-42M	$-59M	$-68M	$-35M	$-23M	$-24M	$-13M	$-11M	$-23M	$-9M	$-8M	$-19M
Interest Income	$3M	$4M	$4M	$1M	$459.0K	$405.0K	$1M	$671.0K	$147.0K	$60.0K	$19.0K	$18.0K
Other Non-op	$-5M	$-10M	$-12M	$124.0K	$1M	$-156.0K	$-656.0K	$-291.0K	$-92.0K	$-94.0K	·	·
Pretax Income	$-44M	$-65M	$-76M	$-33M	$-21M	$-24M	$-12M	$-11M	$-23M	$-9M	$-8M	$-19M
Income Tax	$47.0K	$34.0K	$69.0K	$276.0K	$189.0K	$339.0K	$17.0K	$-37.0K	$81.0K	$-40.0K	$-338.0K	$-256.0K
Net Income	$-44M	$-65M	$-76M	$-34M	$-21M	$-24M	$-12M	$-11M	$-23M	$-9M	$-8M	$-19M
EPS (Basic)	$-0.50	$-0.89	$-1.12	$-0.51	$-0.33	$-0.40	$-0.21	·	·	·	·	·
EPS (Diluted)	$-0.50	$-0.89	$-1.12	$-0.51	$-0.33	$-0.40	$-0.21	·	·	·	·	·
Shares (Basic)	87,142,000	73,408,000	68,131,000	65,344,000	64,568,000	59,360,000	56,525,000	·	·	·	·	·
Shares (Diluted)	87,142,000	73,408,000	68,131,000	65,344,000	64,568,000	59,360,000	56,525,000	·	·	·	·	·
EBITDA	$-36M	$-54M	$-68M	$-35M	$-23M	$-24M	$-13M	$-11M	$-23M	$-9M	$-8M	$-19M

Stato Patrimoniale 29

Dati annuali Stato Patrimoniale per CDXS
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$51M	$19M	$65M	$114M	$117M	$149M	$90M	$53M	$31M	$19M	$23M	$26M
Short-term Investments	$27M	$54M	$0	·	·	·	·	·	·	·	·	·
Receivables	·	·	$10M	$32M	$25M	$14M	$9M	$12M	$11M	$6M	$7M	$4M
Inventory	$2M	$2M	$3M	$2M	$1M	$964.0K	$371.0K	$589.0K	$1M	$825.0K	$992.0K	$1M
Prepaid Expense	$6M	$4M	$5M	$5M	$6M	$3M	$3M	$1M	$984.0K	$1M	$1M	$1M
Other Current Assets	$500.0K	$500.0K	$600.0K	$700.0K	·	·	·	·	·	·	·	·
Current Assets	$97M	$99M	$93M	$163M	$162M	$184M	$114M	$68M	$45M	$27M	$33M	$33M
PP&E (Net)	$13M	$14M	$15M	$23M	$21M	$10M	$6M	$5M	$3M	$2M	$3M	$4M
PP&E (Gross)	$58M	$55M	$55M	$62M	$57M	$43M	$40M	$38M	$35M	$34M	$35M	$37M
Accum. Depreciation	$45M	$41M	$39M	$40M	$36M	$33M	$33M	$33M	$32M	$32M	$32M	$31M
Goodwill	$2M	$2M	$2M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M
Intangibles	·	·	·	·	·	·	·	·	·	$0	$3M	$6M
Other Non-current Assets	$883.0K	$1M	$1M	$350.0K	$276.0K	$294.0K	$178.0K	$1M	$302.0K	$259.0K	$310.0K	$294.0K
Total Assets	$148M	$149M	$137M	$250M	$246M	$222M	$149M	$79M	$54M	$36M	$45M	$48M
Accounts Payable	$2M	$3M	$6M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$3M	$5M
Accrued Liabilities	$3M	$6M	$5M	$15M	$13M	$10M	$7M	$5M	$4M	$2M	$2M	$3M
Current Liabilities	$25M	$24M	$36M	$49M	$33M	$25M	$15M	$18M	$25M	$12M	$15M	$14M
Capital Leases	$30M	$28M	$12M	$38M	$44M	$22M	$25M	$61.0K	$302.0K	·	·	·
Other Non-current Liabilities	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$2M	$2M	$2M	$3M
Total Liabilities	$97M	$82M	$50M	$106M	$82M	$52M	$44M	$23M	$29M	$17M	$22M	·
Long-term Debt	$40M	$29M	·	·	·	·	·	·	·	·	·	·
Total Debt	$40M	$29M	·	·	·	·	·	·	$302.0K	·	·	·
Common Stock	$9.0K	$8.0K	$7.0K	$6.0K	$6.0K	$6.0K	$6.0K	$5.0K	$5.0K	$4.0K	$4.0K	$4.0K
Paid-in Capital	$657M	$630M	$584M	$566M	$552M	$537M	$448M	$387M	$340M	$311M	$306M	$302M
Retained Earnings	$-607M	$-563M	$-498M	$-421M	$-388M	$-366M	$-342M	$-330M	$-315M	$-292M	$-284M	$-276M
AOCI	$8.0K	$52.0K	$0	·	·	·	·	$0	$-472.0K	$0	$405.0K	$-142.0K
Stockholders' Equity	$51M	$67M	$87M	$145M	$164M	$170M	$106M	$56M	$25M	$19M	$23M	$26M
Liabilities + Equity	$148M	$149M	$137M	$250M	$246M	$222M	$149M	$79M	$54M	$36M	$45M	$48M
Shares Outstanding	90,478,000	81,850,000	69,905,000	65,811,000	65,109,000	64,283,000	58,877,000	54,065,000	48,365,000	41,255,000	40,343,000	39,563,000

Flusso di cassa 17

Dati annuali Flusso di cassa per CDXS
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$5M	$5M	$6M	$5M	·	·	·	·	·	·	·	·
Stock-based Comp	$10M	$13M	$10M	$15M	$12M	$8M	$7M	$8M	$7M	$6M	$5M	$5M
Deferred Tax	$-3.0K	$-2.0K	$0	$-7.0K	$-9.0K	$-8.0K	$-6.0K	$-29.0K	$12.0K	$-31.0K	$-330.0K	$110.0K
Amort. of Intangibles	·	·	·	·	·	·	·	$0	$0	$3M	$3M	$3M
Restructuring	$3M	$0	$3M	$3M	$0	$0	·	·	·	·	·	·
Other Non-cash	$10M	$-2M	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-19M	$-49M	$-53M	$11M	$-14M	$-16M	$-13M	$-14M	$-9M	$-2M	$-433.0K	$321.0K
CapEx	$4M	$4M	$4M	$8M	$14M	$4M	$4M	$3M	$985.0K	$888.0K	$1M	$302.0K
Investing Cash Flow	$24M	$-57M	$-5M	$-14M	$-21M	$-6M	$-4M	$-3M	$-983.0K	$-846.0K	$-1M	$5M
Debt Issued	$10M	$30M	$0	$0	·	·	·	·	·	·	·	·
Net Debt Issued	$10M	$30M	·	·	·	·	·	·	·	·	·	·
Stock Issued	$17M	$31M	$9M	$0	$0	$86M	$0	$37M	$24M	$0	$0	$9.0K
Net Stock Activity	$17M	$31M	$9M	$0	$0	$86M	$50M	·	$24M	$0	$0	$9.0K
Financing Cash Flow	$28M	$61M	$8M	$-575.0K	$4M	$81M	$54M	$39M	$22M	$-490.0K	$-2M	$-611.0K
Net Change in Cash	$32M	$-46M	$-49M	$-3M	$-32M	$59M	$38M	$22M	$12M	$-3M	$-3M	$4M
Taxes Paid	·	$17.0K	$194.0K	$100.0K	$102.0K	$312.0K	$5.0K	$5.0K	$32.0K	$5.0K	$8.0K	$15.0K
Free Cash Flow	$-24M	$-54M	$-57M	$3M	$-28M	$-20M	$-16M	$-17M	$-10M	$-4M	$-2M	$19.0K

Redditività 7

Dati annuali Redditività per CDXS
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Operating Margin	-59.3%	-98.6%	-97.0%	-25.2%	-21.7%	-34.6%	-18.3%	-18.6%	-45.9%	-17.5%	-18.6%	-54.1%
Net Margin	-62.5%	-110.0%	-108.7%	-24.2%	-20.3%	-34.8%	-17.4%	-17.9%	-46.0%	-17.5%	-18.1%	-54.0%
Pretax Margin	-62.4%	-109.9%	-108.6%	-24.0%	-20.1%	-34.3%	-17.4%	-18.0%	-45.8%	-17.6%	-18.9%	-54.7%
EBITDA Margin	-51.8%	-90.3%	-97.0%	-25.2%	-21.7%	-34.6%	-18.3%	-18.6%	-45.9%	-17.5%	-18.6%	-54.1%
ROA	-29.6%	-45.7%	-39.4%	-13.5%	-9.1%	-13.0%	-10.4%	-16.4%	-51.5%	-21.3%	-16.3%	-35.7%
ROE	-82.8%	-93.0%	-85.6%	-22.5%	-12.8%	-18.4%	-11.5%	-19.6%	-98.6%	-40.8%	-30.8%	-56.3%
ROIC	-46.1%	-61.1%	-78.7%	-24.3%	-13.9%	-14.3%	-11.9%	-20.0%	-92.8%	-44.6%	-32.5%	-71.7%

Liquidità e Solvibilità 4

Dati annuali Liquidità e Solvibilità per CDXS
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	3.8	4.2	2.6	3.3	4.9	7.4	7.4	3.8	1.8	2.2	2.2	2.4
Quick Ratio	3.1	3.1	2.1	3.0	4.2	6.5	6.5	3.6	1.7	2.0	2.1	2.2
Debt / Equity	0.8	0.4	·	·	·	·	·	·	0.0	·	·	·
LT Debt / Equity	0.8	0.4	·	·	·	·	·	·	0.0	·	·	·

Efficienza 3

Dati annuali Efficienza per CDXS
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.5	0.4	0.4	0.6	0.4	0.4	0.6	0.9	1.1	1.2	0.9	0.7
Inventory Turnover	5.2	7.3	5.4	23.9	20.9	20.6	32.6	15.5	15.4	10.7	5.5	6.7
Receivables Turnover	·	·	3.3	4.9	5.4	6.0	6.7	5.3	5.6	7.4	7.5	7.6

Per Azione 5

Dati annuali Per Azione per CDXS
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$0.56	$0.82	$1.24	$2.20	$2.52	$2.65	$1.79	$1.03	$0.51	$0.46	$0.57	$0.67
Revenue / Share	$0.81	$0.81	$1.03	$2.12	$1.62	·	·	·	·	·	·	·
Cash Flow / Share	$-0.22	$-0.67	$-0.77	$0.17	$-0.22	·	·	·	·	·	·	·
Cash / Share	$0.56	$0.24	$0.93	$1.73	$1.79	$2.32	$1.54	$0.97	$0.65	$0.47	$0.58	$0.67
EPS (TTM)	$-0.50	$-0.89	$-1.12	$-0.51	$-0.33	$-0.40	$-0.21	·	·	·	·	·

Tassi di Crescita 3

Dati annuali Tassi di Crescita per CDXS
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	18.6%	-15.4%	-49.4%	32.3%	51.7%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-20.2%	-17.3%	0.52%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	0.38%	·	·	·	·	·	·	·	·	·	·	·

Valutazione (TTM) 14

Dati annuali Valutazione (TTM) per CDXS
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$70M	$59M	$70M	$139M	$105M	$69M	$68M	$61M	$50M	$49M	$42M	$35M
Net Income TTM	$-44M	$-65M	$-76M	$-34M	$-21M	$-24M	$-12M	$-11M	$-23M	$-9M	$-8M	$-19M
Market Cap	$147M	$390M	$213M	$307M	$2.04B	$1.40B	$941M	$912M	$404M	$190M	$171M	$100M
Enterprise Value	$109M	$346M	·	·	·	·	·	·	$373M	·	·	·
P/E	-3.3	-5.4	-2.7	-9.1	-94.8	-54.6	-76.1	·	·	·	·	·
P/S	2.1	6.6	3.0	2.2	19.4	20.3	13.8	15.0	8.1	3.9	4.1	2.8
P/B	2.9	5.8	2.5	2.1	12.4	8.2	8.9	16.2	16.5	9.9	7.5	3.8
P / Tangible Book	3.1	6.1	2.5	2.2	12.6	8.4	·	·	·	·	·	·
P / Cash Flow	-7.6	-7.9	-4.1	27.2	-142.7	-85.2	-75.0	-64.7	-46.1	-70.3	-394.1	310.6
P / FCF	-6.2	-7.3	-3.7	103.0	-72.5	-69.4	-57.8	-54.1	-41.4	-52.9	-104.6	5247.3
EV / EBITDA	-3.0	-6.5	·	·	·	·	·	·	-16.2	·	·	·
EV / FCF	-4.6	-6.4	·	·	·	·	·	·	-38.3	·	·	·
EV / Revenue	1.6	5.8	·	·	·	·	·	·	7.5	·	·	·
Earnings Yield	-30.7%	-18.7%	-36.7%	-10.9%	-1.1%	-1.8%	-1.3%	·	·	·	·	·

Conto Economico 16

Dati trimestrali Conto Economico per CDXS
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$15M	$15M	$39M	$9M	$15M	$8M	$21M	$13M	$8M	$17M	$27M	$9M	$21M	$13M	$30M	$34M
Cost of Revenue	$4M	$2M	$2M	$2M	$2M	$3M	$4M	$4M	$3M	$5M	$3M	$2M	$3M	$5M	$8M	$10M
R&D Expense	$12M	$11M	$12M	$14M	$14M	$13M	$12M	$12M	$11M	$11M	$11M	$14M	$17M	$17M	$20M	$22M
SG&A Expense	$11M	$10M	$11M	$11M	$12M	$12M	$13M	$14M	$16M	$13M	$12M	$12M	$13M	$15M	$12M	$13M
Operating Expenses	$26M	$23M	$28M	$28M	$28M	$28M	$29M	$29M	$31M	$29M	$26M	$41M	$34M	$37M	$44M	$45M
Operating Income	$-11M	$-8M	$11M	$-19M	$-13M	$-20M	$-7M	$-17M	$-23M	$-12M	$282.0K	$-32M	$-13M	$-24M	$-13M	$-11M
Interest Income	$535.0K	$665.0K	$656.0K	$634.0K	$584.0K	$751.0K	$940.0K	$849.0K	$972.0K	$909.0K	$906.0K	$1M	$1M	$1M	$823.0K	$436.0K
Other Non-op	$-1M	$-1M	$-2M	$-1M	$-984.0K	$-942.0K	$-4M	$-5M	$-985.0K	$-516.0K	$-8M	$-4M	$-9.0K	$-25.0K	$-26.0K	$216.0K
Pretax Income	$-12M	$-9M	$10M	$-20M	$-13M	$-21M	$-10M	$-21M	$-23M	$-11M	$-7M	$-35M	$-12M	$-23M	$-12M	$-10M
Income Tax	$10.0K	$36.0K	$18.0K	$8.0K	$10.0K	$11.0K	$4.0K	$10.0K	$10.0K	$10.0K	$35.0K	$9.0K	$9.0K	$16.0K	$151.0K	$8.0K
Net Income	$-12M	$-9M	$10M	$-20M	$-13M	$-21M	$-10M	$-21M	$-23M	$-12M	$-7M	$-35M	$-12M	$-23M	$-13M	$-10M
EPS (Basic)	$-0.13	$-0.10	$0.13	$-0.22	$-0.16	$-0.25	$-0.12	$-0.29	$-0.32	$-0.16	$-0.11	$-0.50	$-0.17	$-0.34	$-0.19	$-0.15
EPS (Diluted)	$-0.13	$-0.10	$0.13	$-0.22	$-0.16	$-0.25	$-0.12	$-0.29	$-0.32	$-0.16	$-0.11	$-0.50	$-0.17	$-0.34	$-0.19	$-0.15
Shares (Basic)	91,053,000	90,768,000	-170,908,000	90,251,000	85,389,000	82,410,000	-138,854,000	72,032,000	70,376,000	69,854,000	-134,839,000	69,466,000	67,573,000	65,931,000	-130,466,000	65,426,000
Shares (Diluted)	91,053,000	90,768,000	-170,908,000	90,251,000	85,389,000	82,410,000	-138,854,000	72,032,000	70,376,000	69,854,000	-134,839,000	69,466,000	67,573,000	65,931,000	-130,466,000	65,426,000
EBITDA	$-11M	·	·	$-19M	$-13M	$-19M	·	$-17M	$-23M	$-12M	·	$-32M	$-13M	$-24M	·	$-11M

Stato Patrimoniale 27

Dati trimestrali Stato Patrimoniale per CDXS
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$27M	$37M	$51M	$25M	$27M	$18M	$19M	$37M	$19M	$58M	$65M	$75M	$92M	$103M	$114M	$109M
Short-term Investments	$28M	$29M	$27M	$33M	$40M	$41M	$54M	$53M	$55M	$27M	·	·	·	·	·	·
Inventory	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	·	$2M	$2M	$2M	·	$2M
Prepaid Expense	$3M	$4M	$6M	$5M	$3M	$4M	$4M	$3M	$3M	$5M	·	$5M	$4M	$5M	·	$5M
Other Current Assets	$500.0K	$400.0K	$500.0K	$500.0K	$100.0K	$500.0K	$500.0K	$300.0K	$900.0K	$500.0K	·	·	·	·	·	·
Current Assets	$72M	$80M	$97M	$76M	$89M	$78M	$99M	$113M	$91M	$108M	·	$103M	$120M	$130M	·	$146M
PP&E (Net)	$12M	$13M	$13M	$14M	$15M	$16M	$14M	$13M	$14M	$15M	·	$15M	$23M	$24M	·	$23M
PP&E (Gross)	$59M	$59M	$58M	$58M	$58M	$57M	$55M	$54M	$54M	$55M	·	$54M	$66M	$65M	·	$63M
Accum. Depreciation	$47M	$46M	$45M	$44M	$43M	$42M	$41M	$41M	$40M	$40M	·	$39M	$42M	$41M	·	$39M
Goodwill	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	·	$2M	$3M	$3M	$3M	$3M
Other Non-current Assets	$1M	$994.0K	$883.0K	$912.0K	$950.0K	$967.0K	$1M	$2M	$2M	$1M	·	$726.0K	$498.0K	$415.0K	·	$208.0K
Total Assets	$120M	$129M	$148M	$124M	$138M	$129M	$149M	$148M	$132M	$150M	·	$154M	$207M	$218M	·	$235M
Accounts Payable	$3M	$2M	$2M	$2M	$1M	$6M	$3M	$4M	$4M	$3M	·	$3M	$4M	$4M	·	$3M
Accrued Liabilities	$3M	$3M	$3M	$3M	$3M	$5M	$6M	$7M	$5M	$5M	·	$9M	$7M	$8M	·	$13M
Current Liabilities	$24M	$15M	$25M	$18M	$15M	$21M	$24M	$35M	$31M	$29M	·	$38M	$36M	$38M	·	$32M
Capital Leases	$28M	$29M	$30M	$26M	$27M	$27M	$28M	$9M	$10M	$11M	·	$13M	$35M	$37M	·	$40M
Other Non-current Liabilities	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	·	$1M	$1M	$1M	·	$1M
Total Liabilities	$87M	$86M	$97M	$85M	$83M	$79M	$82M	$75M	$71M	$70M	·	$63M	$83M	$92M	·	$81M
Long-term Debt	$41M	$40M	$40M	$40M	$39M	$29M	·	$29M	$28M	$28M	·	·	·	·	·	·
Total Debt	$41M	·	·	$40M	$39M	$29M	·	$29M	$28M	$28M	·	·	·	·	·	·
Common Stock	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$8.0K	$8.0K	$8.0K	$7.0K	$7.0K	·	$6.0K	$6.0K	$6.0K	·	$6.0K
Paid-in Capital	$660M	$659M	$657M	$655M	$652M	$633M	$630M	$626M	$593M	$588M	·	$582M	$580M	$570M	·	$563M
Retained Earnings	$-627M	$-615M	$-607M	$-616M	$-597M	$-583M	$-563M	$-552M	$-532M	$-509M	·	$-490M	$-455M	$-444M	·	$-409M
AOCI	$-13.0K	$-11.0K	$8.0K	$12.0K	$-3.0K	$14.0K	$52.0K	$126.0K	$-23.0K	$-16.0K	·	·	·	·	·	·
Stockholders' Equity	$33M	$43M	$51M	$39M	$56M	$50M	$67M	$73M	$61M	$79M	$87M	$92M	$124M	$126M	$145M	$154M
Liabilities + Equity	$120M	$129M	$148M	$124M	$138M	$129M	$149M	$148M	$132M	$150M	·	$154M	$207M	$218M	·	$235M
Shares Outstanding	91,388,000	90,894,000	90,478,000	90,281,000	90,254,000	82,841,000	81,850,000	81,376,000	70,914,000	70,554,000	·	69,827,000	69,804,000	66,696,000	·	65,613,000

Flusso di cassa 15

Dati trimestrali Flusso di cassa per CDXS
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	·	·	·	·
Stock-based Comp	$2M	$1M	$2M	$3M	$3M	$2M	$3M	$3M	$5M	$3M	$2M	$2M	$3M	$3M	$3M	$5M
Restructuring	·	·	·	·	·	·	$0	$0	$0	$0	$0	$3M	$72.0K	$72.0K	$3M	$0
Other Non-cash	·	·	·	·	·	$3M	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-10M	$-13M	$20M	$-8M	$-18M	$-14M	$-16M	$-13M	$-12M	$-8M	$-11M	$-16M	$-16M	$-9M	$5M	$20M
CapEx	$898.0K	$176.0K	$520.0K	$182.0K	$3M	$1M	$2M	$1M	$395.0K	$1M	$-380.0K	$678.0K	$2M	$3M	$-33.0K	$1M
Investing Cash Flow	$175.0K	$-1M	$6M	$6M	$-367.0K	$12M	$-3M	$2M	$-27M	$-29M	$1M	$-1M	$-2M	$-3M	$33.0K	$-1M
Debt Issued	·	·	$0	$0	$10M	$0	$0	$0	$0	$30M	$0	$0	$0	$0	·	·
Net Debt Issued	·	·	·	·	·	$0	·	·	·	$30M	·	·	·	·	·	·
Stock Issued	·	·	$-1.0K	$0	·	·	$-1.0K	$31M	$0	$0	$0	$0	$7M	$2M	$0	$0
Net Stock Activity	·	·	·	·	·	·	·	·	·	$0	·	·	·	$2M	·	·
Financing Cash Flow	$66.0K	$-14.0K	$180.0K	$-111.0K	$27M	$1M	$1M	$30M	$-197.0K	$29M	$0	$-108.0K	$7M	$1M	$339.0K	$133.0K
Net Change in Cash	$-9M	$-14M	$26M	$-1M	$8M	$-944.0K	$-18M	$19M	$-39M	$-7M	$-10M	$-18M	$-11M	$-11M	$5M	$19M
Taxes Paid	·	·	·	·	·	$0	·	·	·	$17.0K	·	·	·	·	·	·
Free Cash Flow	·	·	·	·	·	$-15M	·	·	·	$-9M	·	·	·	$-12M	·	·

Redditività 7

Dati trimestrali Redditività per CDXS
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-75.3%	·	·	-220.3%	-83.9%	-271.6%	·	-129.0%	-284.9%	-69.6%	·	-345.6%	-59.2%	-182.3%	·	-30.9%
Net Margin	-80.5%	·	·	-228.1%	-86.6%	-274.3%	·	-160.8%	-285.2%	-67.4%	·	-376.3%	-54.0%	-174.2%	·	-29.0%
Pretax Margin	-80.4%	·	·	-228.0%	-86.5%	-274.1%	·	-160.8%	-285.1%	-67.3%	·	-376.2%	-54.0%	-174.1%	·	-29.0%
EBITDA Margin	-75.3%	·	·	-220.3%	-83.9%	-255.8%	·	-129.0%	-284.9%	-69.6%	·	-345.6%	-59.2%	-182.3%	·	-30.9%
ROA	-9.3%	·	·	-14.4%	-9.8%	-14.9%	·	-13.6%	-13.4%	-6.3%	·	-17.9%	-5.2%	-10.0%	·	-4.3%
ROE	-27.1%	·	·	-35.0%	-22.7%	-32.1%	·	-25.0%	-24.5%	-11.2%	·	-28.4%	-8.1%	-15.9%	·	-6.2%
ROIC	-15.2%	·	·	-24.2%	-13.6%	-26.0%	·	-16.2%	-25.3%	-11.1%	·	-35.0%	-10.2%	-18.8%	·	-6.9%

Liquidità e Solvibilità 4

Dati trimestrali Liquidità e Solvibilità per CDXS
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	3.1	·	·	4.1	5.8	3.7	·	3.2	3.0	3.7	·	2.7	3.4	3.4	·	4.6
Quick Ratio	2.3	·	·	3.2	4.4	2.9	·	2.6	2.4	2.9	·	1.9	2.6	2.7	·	3.4
Debt / Equity	1.2	·	·	1.0	0.7	0.6	·	0.4	0.5	0.4	·	·	·	·	·	·
LT Debt / Equity	1.0	·	·	1.0	0.7	0.6	·	0.4	0.5	0.4	·	·	·	·	·	·

Efficienza 2

Dati trimestrali Efficienza per CDXS
Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.1	·	·	0.1	0.1	0.1	·	0.1	0.0	0.1	·	0.0	0.1	0.1	·	0.1
Inventory Turnover		2.0	·	·	1.2	1.0	1.3	·	2.0	1.6	2.2	·	1.1	1.7	2.5	·	7.2

Per Azione 5

Dati trimestrali Per Azione per CDXS
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.36	·	·	$0.43	$0.62	$0.60	·	$0.90	$0.87	$1.12	·	$1.31	$1.78	$1.89	·	$2.35
Revenue / Share	$0.16	·	·	$0.10	$0.18	$0.09	·	$0.18	$0.11	$0.24	·	$0.13	$0.32	$0.20	·	$0.53
Cash Flow / Share	·	·	·	·	·	$-0.17	·	·	·	$-0.11	·	·	·	$-0.14	·	·
Cash / Share	$0.30	·	·	$0.28	$0.30	$0.22	·	$0.46	$0.26	$0.82	·	$1.07	$1.32	$1.54	·	$1.66
EPS (TTM)	$-0.61	$-0.73	·	$-0.92	$-1.02	$-1.02	·	$-1.27	$-1.15	$-1.17	·	$-1.16	$-0.70	$-0.66	·	$-0.29

Valutazione (TTM) 14

Dati trimestrali Valutazione (TTM) per CDXS
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$54M	$47M	·	$44M	$44M	$45M	·	$47M	$56M	$61M	·	$78M	$107M	$121M	·	$145M
Net Income TTM	$-54M	$-62M	·	$-74M	$-77M	$-76M	·	$-90M	$-81M	$-81M	·	$-79M	$-47M	$-44M	·	$-19M
Market Cap	$207M	·	·	$220M	$220M	$223M	·	$251M	$220M	$246M	·	$132M	$195M	$276M	·	$398M
Enterprise Value	$192M	·	·	$201M	$193M	$192M	·	$189M	$175M	$189M	·	·	·	·	·	·
P/E	-3.7	-2.2	·	-2.7	-2.4	-2.6	·	-2.4	-2.7	-3.0	·	-1.6	-4.0	-6.3	·	-20.9
P/S	3.8	·	·	5.0	5.0	4.9	·	5.3	4.0	4.1	·	1.7	1.8	2.3	·	2.7
P/B	6.3	·	·	5.7	4.0	4.5	·	3.4	3.6	3.1	·	1.4	1.6	2.2	·	2.6
P / Tangible Book	6.8	3.6	·	6.1	4.1	4.7	·	3.5	3.7	3.2	·	1.5	1.6	2.2	·	2.6
P / Cash Flow	·	·	·	·	·	-16.2	·	·	·	-31.6	·	·	·	-30.0	·	·
P / FCF	·	·	·	·	·	-14.8	·	·	·	-27.6	·	·	·	-23.5	·	·
EV / EBITDA	-17.1	·	·	-10.6	-15.0	-10.0	·	-11.4	-7.7	-15.9	·	·	·	·	·	·
EV / FCF	·	·	·	·	·	-12.8	·	·	·	-21.2	·	·	·	·	·	·
EV / Revenue	3.6	·	·	4.5	4.4	4.2	·	4.0	3.1	3.1	·	·	·	·	·	·
Earnings Yield	-27.0%	-44.8%	·	-37.7%	-41.8%	-37.9%	·	-41.2%	-37.1%	-33.5%	·	-61.4%	-25.0%	-15.9%	·	-4.8%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$70M	$59M	$70M	$139M	$105M
Margine Operativo %	-59.3%	-98.6%	-97.0%	-25.2%	-21.7%
Utile netto	$-44M	$-65M	$-76M	$-34M	$-21M
EPS Diluito	$-0.50	$-0.89	$-1.12	$-0.51	$-0.33

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	0.8	0.4	—	—	—
Rapporto corrente	3.8	4.2	2.6	3.3	4.9
Quick Ratio	3.1	3.1	2.1	3.0	4.2

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-24M	$-54M	$-57M	$3M	$-28M

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 156 filer · $120.9M totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
32 (+4 vs trimestre precedente)	11 (-10 vs trimestre precedente)	50 (+4 vs trimestre precedente)	41 (+8 vs trimestre precedente)	+6.7M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
Opaleye Management Inc.	$15.334.100	6.785.000	12,69%	Azioni
Aberdeen Group plc	$15.300.096	6.769.954	12,66%	Azioni
MILLENNIUM MANAGEMENT LLC	$12.541.054	5.549.139	10,38%	Azioni
Telemark Asset Management, LLC	$8.692.889	3.846.411	7,19%	Azioni
AMERIPRISE FINANCIAL INC	$8.609.334	3.809.440	7,12%	Azioni
Nantahala Capital Management, LLC	$8.189.365	3.623.613	6,78%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$8.174.666	3.617.109	6,76%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$4.204.899	1.860.140	3,48%	Azioni
STATE STREET CORP	$3.970.400	1.756.814	3,29%	Azioni
JACOBS LEVY EQUITY MANAGEMENT, INC	$3.006.263	1.330.205	2,49%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$2.954.206	1.307.171	2,44%	Azioni
Assenagon Asset Management S.A.	$2.888.746	1.278.206	2,39%	Azioni
D. E. Shaw & Co., Inc.	$2.500.229	1.106.296	2,07%	Azioni
Tallon Kerry Patrick	$2.018.337	403.667	1,67%	Azioni
TWO SIGMA INVESTMENTS, LP	$1.574.314	696.599	1,30%	Azioni
FRANKLIN RESOURCES INC	$1.533.726	678.640	1,27%	Azioni
VANGUARD FIDUCIARY TRUST CO	$1.313.191	581.058	1,09%	Azioni
Man Group plc	$1.278.240	565.593	1,06%	Azioni
Post Resch Tallon Group Inc.	$1.273.460	563.478	1,05%	Azioni
PERKINS CAPITAL MANAGEMENT INC	$1.188.986	526.100	0,98%	Azioni
ALGERT GLOBAL LLC	$973.857	430.910	0,81%	Azioni
TUDOR INVESTMENT CORP ET AL	$808.910	357.925	0,67%	Azioni
BlackRock, Inc.	$648.681	287.027	0,54%	Azioni
PLATINUM INVESTMENT MANAGEMENT LTD	$597.689	264.464	0,49%	Azioni
Potomac Capital Management, Inc.	$587.600	260.000	0,49%	Azioni
DIMENSIONAL FUND ADVISORS LP	$583.674	258.263	0,48%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$547.397	242.211	0,45%	Azioni
XTX Topco Ltd	$543.817	240.627	0,45%	Azioni
UBS Group AG	$542.188	239.906	0,45%	Azioni
FMR LLC	$457.501	202.434	0,38%	Azioni
GOLDMAN SACHS GROUP INC	$389.726	172.445	0,32%	Azioni
Cubist Systematic Strategies, LLC	$359.610	147.381	0,30%	Azioni
BARCLAYS PLC	$347.740	153.867	0,29%	Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$334.595	148.051	0,28%	Azioni
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$284.552	125.908	0,24%	Azioni
STRS OHIO	$273.460	121.000	0,23%	Azioni
JANE STREET GROUP, LLC	$261.857	115.866	0,22%	Azioni
MARSHALL WACE, LLP	$254.791	112.739	0,21%	Azioni
Stonepine Capital Management, LLC	$247.836	109.662	0,21%	Azioni
RHUMBLINE ADVISERS	$233.449	103.301	0,19%	Azioni
CITADEL ADVISORS LLC	$227.295	100.573	0,19%	Azioni
ALLIANCEBERNSTEIN L.P.	$206.081	126.430	0,17%	Azioni
WELLS FARGO & COMPANY/MN	$176.113	77.926	0,15%	Azioni
Bank of New York Mellon Corp	$174.178	77.070	0,14%	Azioni
LPL Financial LLC	$173.026	76.560	0,14%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$161.879	71.628	0,13%	Azioni
BANK OF AMERICA CORP /DE/	$145.582	64.417	0,12%	Azioni
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	$144.082	63.753	0,12%	Azioni
Numerai GP LLC	$136.072	60.209	0,11%	Azioni
PANAGORA ASSET MANAGEMENT INC	$131.532	58.200	0,11%	Azioni
Mariner, LLC	$123.484	54.637	0,10%	Azioni
MetLife Investment Management, LLC	$117.545	52.011	0,10%	Azioni
ENVESTNET ASSET MANAGEMENT INC	$116.108	51.375	0,10%	Azioni
LOS ANGELES CAPITAL MANAGEMENT LLC	$108.763	48.125	0,09%	Azioni
IEQ CAPITAL, LLC	$104.559	46.265	0,09%	Azioni
TWO SIGMA ADVISERS, LP	$96.822	59.400	0,08%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$93.790	41.500	0,08%	Azioni
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	$89.957	39.804	0,07%	Azioni
CITIGROUP INC	$86.660	38.345	0,07%	Azioni
Frec Markets, Inc.	$84.228	37.269	0,07%	Azioni
OSAIC HOLDINGS, INC.	$82.186	36.366	0,07%	Azioni
COMMONWEALTH EQUITY SERVICES, LLC	$81.820	36.204	0,07%	Azioni
BANK OF MONTREAL /CAN/	$79.095	34.998	0,07%	Azioni
Krilogy Financial LLC	$78.705	34.825	0,07%	Azioni
MORGAN STANLEY	$77.462	34.275	0,06%	Azioni
Invesco Ltd.	$77.181	34.151	0,06%	Azioni
Dynamic Technology Lab Private Ltd	$74.000	33.000	0,06%	Azioni
Vanguard Global Advisers, LLC	$73.681	32.602	0,06%	Azioni
MERCER GLOBAL ADVISORS INC /ADV	$73.111	32.350	0,06%	Azioni
AMERICAN CENTURY COMPANIES INC	$68.932	30.501	0,06%	Azioni
BLAIR WILLIAM & CO/IL	$68.295	30.219	0,06%	Azioni
EVERGREEN CAPITAL MANAGEMENT LLC	$65.540	29.000	0,05%	Azioni
CWM, LLC	$63.696	39.077	0,05%	Azioni
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	$61.418	25.275	0,05%	Azioni
Nuveen Asset Management, LLC	$59.902	12.558	0,05%	Azioni
PRUDENTIAL FINANCIAL INC	$59.619	26.380	0,05%	Azioni
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$56.963	25.205	0,05%	Azioni
Cerity Partners LLC	$53.695	23.759	0,04%	Azioni
VANGUARD GROUP INC	$53.141	32.602	0,04%	Azioni
INTECH INVESTMENT MANAGEMENT LLC	$48.486	21.454	0,04%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$45.426	20.100	0,04%	Opzione Call
Police & Firemen's Retirement System of New Jersey	$43.937	19.441	0,04%	Azioni
VOYA INVESTMENT MANAGEMENT LLC	$41.948	18.561	0,03%	Azioni
Vanguard Personalized Indexing Management, LLC	$40.562	17.948	0,03%	Azioni
Simplicity Wealth,LLC	$39.410	17.438	0,03%	Azioni
NEW YORK STATE COMMON RETIREMENT FUND	$38.167	16.888	0,03%	Azioni
CITADEL ADVISORS LLC	$35.708	15.800	0,03%	Opzione Call
Creative Planning	$35.003	15.488	0,03%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$34.942	15.461	0,03%	Azioni
Navalign, LLC	$34.668	15.340	0,03%	Azioni
EP Wealth Advisors, LLC	$34.526	15.277	0,03%	Azioni
China Universal Asset Management Co., Ltd.	$32.693	14.466	0,03%	Azioni
ProShare Advisors LLC	$32.324	14.303	0,03%	Azioni
Elmwood Wealth Management, Inc.	$28.691	12.695	0,02%	Azioni
NORTHERN TRUST CORP	$27.992	12.386	0,02%	Azioni
OXFORD ASSET MANAGEMENT LLP	$27.335	12.095	0,02%	Azioni
Graham Capital Management, L.P.	$27.287	12.074	0,02%	Azioni
Tower Research Capital LLC (TRC)	$27.244	12.055	0,02%	Azioni
Abel Hall, LLC	$26.930	11.916	0,02%	Azioni
Caerus Investment Advisors, LLC	$26.297	11.636	0,02%	Azioni

Insider aziendali 40 insider · 19 dirigenti · 20 direttori

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
John J Nicols	President and CEO	11 Giugno 2018 M	1.072.679	0	$0
Peter M Strumph	Interim President and CEO	01 Giugno 2012 A	60.756	0	$0
Alan Shaw	President and CEO	16 Dicembre 2011 S	202.000	0	$0
Georgia Erbez	Chief Financial Officer	05 Febbraio 2025 A	76.875	0	$0
Sriram Ryali	Chief Financial Officer	01 Gennaio 2024 A	175.791	0	$0
Gordon Sangster	SVP & Chief Financial Officer	24 Maggio 2018 S	153.189	0	$0
David D O'Toole	SVP & Chief Financial Officer	04 Settembre 2013 F	110.687	0	$0
Brian Paul Dowd	Interim CFO	01 Giugno 2012 A	28.310	0	$0
Robert J Lawson	SVP and CFO	11 Maggio 2011 P	44.000	0	$0
Kevin Norrett	Chief Operating Officer	05 Febbraio 2025 A	177.327	0	$0
Alison Moore	Chief Technical Officer	05 Febbraio 2025 A	175.571	0	$0
Margaret Nell Fitzgerald	Chief Legal and Compliance Officer	01 Gennaio 2024 A	133.770	0	$0
James Lalonde	SVP, R&D	17 Luglio 2018 S	195.066	0	$0
Michael D. Aldridge	Senior Vice President, Corporate & Strategic Development	17 Maggio 2018 M	0	0	$0
Douglas T. Sheehy	EVP, Chief Administrative Officer, General Counsel & Secretary	05 Marzo 2016 F	247.617	0	$0
Matthew Tobin	SVP, Research & Development	16 Maggio 2013 M	78.707	0	$0
David L. Anton	SVP, BioIndustrials	10 Febbraio 2013 F	93.777	0	$0
Seufer-Wasserthal Peter	SVP, Pharmaceuticals	24 Gennaio 2013 A	93.064	0	$0
Joseph J. Sarret	SVP and CBO	07 Marzo 2012 A	74.000	0	$0
Raymond De Vre	Direttore	17 Giugno 2026 A	84.811	1	$-6.174
Esther Martinborough	Direttore	17 Giugno 2026 A	129.036	0	$0
Christos Richards	Direttore	17 Giugno 2026 A	85.133	0	$0
Cynthia Collins	Direttore	17 Giugno 2026 A	112.157	0	$0
Stephen George Dilly	Direttore	17 Giugno 2026 A	673.053	0	$0
Rahul Singhvi	Direttore	17 Giugno 2026 A	137.052	0	$0
David V Smith	Direttore	17 Giugno 2026 A	105.705	0	$0
PARKER H STEWART	Direttore	17 Giugno 2026 A	143.583	0	$0
Dennis P Wolf	Direttore	10 Giugno 2025 A	147.903	0	$0
Byron L Dorgan	Direttore	11 Giugno 2024 A	223.581	0	$0
Patrick Y Yang	Direttore	19 Luglio 2018 S	304.157	0	$0
Kathleen Sereda Glaub	Direttore	18 Luglio 2018 S	98.120	0	$0
Thomas R Baruch	Direttore	26 Giugno 2018 S	153.093	0	$0
Bernard J Kelley	Direttore	21 Giugno 2018 S	225.668	0	$0
Pam P. Cheng	Direttore	11 Giugno 2018 A	64.642	0	$0
Alexander Karsner	Direttore	02 Gennaio 2014 A	78.519	0	$0
Bruce A Pasternack	Direttore	24 Agosto 2010 P	10.000	0	$0
James R Sulat	Direttore	27 Aprile 2010 J	5.957.108	0	$0
Brazil Holding B.V. Shell	Proprietario del 10%	31 Maggio 2011 J	5.573.319	0	$0
Equilon Enterprises LLC	Proprietario del 10%	20 Maggio 2011 J	5.573.319	0	$0
MAXYGEN INC	Proprietario del 10%	14 Dicembre 2010 J	524.643	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 3 partecipazioni

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
John Nicols	16 Febbraio 2021	—	Deposito iniziale	—	SEC
– I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAÍZEN ENERGIA S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON SHELL BRAZIL HOLDING B.V., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COMÉRCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN INVESTIMENTOS E PARTICIPAÇÕES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED ×2 depositi	26 Maggio 2015	—	Deposito iniziale	—	SEC
– I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAIZEN ENERGIA PARTICIPA Ç Õ ES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ISPAGNAC PARTICIPA Ç Õ ES LTDA., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COM É RCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED	07 Giugno 2011	—	Deposito iniziale	—	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Proprietà ETF Posseduti da 26 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
QQQS · Invesco Exchange-Traded Fund Trust …	0,26%	40.370 SH	08 Agosto 2026	Giornaliero
IWC · iShares Trust	0,03%	290.804 SH	08 Agosto 2026	Giornaliero
BIB · ProShares Trust	0,01%	3.341 NS	31 Maggio 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	496.936 SH	08 Agosto 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,01%	78.444 SH	08 Agosto 2026	Giornaliero
IBB · iShares Trust	0,01%	613.531 SH	08 Agosto 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,01%	4.900 SH	08 Agosto 2026	Giornaliero
RSSL · Global X Funds	0,01%	38.712 NS	30 Aprile 2026	N-PORT
IWO · iShares Trust	0,01%	679.206 SH	08 Agosto 2026	Giornaliero
ITWO · ProShares Trust	0,01%	4.198 NS	31 Maggio 2026	N-PORT
IWM · iShares Trust	0,00%	2.240.076 SH	08 Agosto 2026	Giornaliero
UWM · ProShares Trust	0,00%	3.283 NS	31 Maggio 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,00%	71.405 SH	08 Agosto 2026	Giornaliero
AVSC · AMERICAN CENTURY ETF TRUST	0,00%	28.868 NS	31 Maggio 2026	N-PORT
URTY · ProShares Trust	0,00%	3.320 NS	31 Maggio 2026	N-PORT
IWN · iShares Trust	0,00%	128.823 SH	08 Agosto 2026	Giornaliero
HDG · ProShares Trust	0,00%	83 NS	31 Maggio 2026	N-PORT
DFAS · Dimensional ETF Trust	0,00%	52.788 NS	30 Aprile 2026	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0,00%	2.554 NS	31 Maggio 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	1.729 NS	30 Aprile 2026	N-PORT
IWV · iShares Trust	0,00%	16.926 SH	08 Agosto 2026	Giornaliero
DFAC · Dimensional ETF Trust	0,00%	19.277 NS	30 Aprile 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	895.869 SH	08 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	2.633.770 SH	08 Agosto 2026	Giornaliero
VTWV · VANGUARD SCOTTSDALE FUNDS	0,00%	9.454 SH	08 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	6.744 SH	08 Agosto 2026	Giornaliero

Informazioni su Codexis, Inc. - Common Stock Panoramica della società da Wikipedia

History

Pharmaceutical

Nutrition

Biotherapeutics

Life science

Technology

CDXS Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

CDXS Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

CDXS Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

Proprietari istituzionali (13F) 156 filer · $120.9M totale · Aggiornato al 30 Giugno 2026

Insider aziendali 40 insider · 19 dirigenti · 20 direttori

Attivisti e proprietari del 5%+ 3 partecipazioni

Proprietà ETF Posseduti da 26 ETF